Impact of systemic dexamethasone administration on oral mucositis induced by anthracycline-containing regimens in breast cancer treatment

HIGHLIGHTS

• who: Yoshitaka Saito from the DepartmentHokkaido University have published the research: Impact of systemic dexamethasone administration on oral mucositis induced by anthracycline-containing regimens in breast cancer treatment, in the Journal: Scientific Reports Scientific Reports
• what: The authors evaluated whether DEX dosage alteration affected OM incidence and severity in anthracycline-containing regimens in a real-world setting. The authors evaluated the risk factors based on these reports and found that lower DEX administration is the only independent risk factor for all-grade OM incidence. This study had some limitations regarding the evaluation of the impact . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.